Abbott Laboratories (NYSE: ABT) has contributed significantly to COVID care activities by providing test kits, and the healthcare conglomerate’s revenues benefitted from
Key factors to consider before investing in Abbott Laboratories (ABT)
Categories
Medical Devices
ANGO Earnings: AngioDynamics reports loss for Q3; revenue up 9%
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported a wider loss for the third quarter when the medical device maker's revenues increased by
Agilent (A) Q1 2023 earnings rise on higher revenues
Agilent Technologies (NYSE: A) has announced first-quarter 2023 financial results, reporting an increase in adjusted profit and revenues. The Santa Clara, California-based
Agilent Technologies Inc (A) Q1 2023 Earnings Call Transcript
Agilent Technologies Inc (NYSE:A) Q1 2023 Earnings Call dated Feb. 28, 2023. Corporate Participants: Parmeet Ahuja -- Investor Relations Mike McMullen -- President and Chief Executive
Medtronic PLC (MDT) Q3 2023 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q3 2023 earnings call dated Feb. 21, 2023 Corporate Participants: Ryan Weispfenning -- Vice President and Head of Investor Relations
Key highlights from Medtronic’s (MDT) Q3 2023 earnings results
Medtronic plc (NYSE: MDT) reported third quarter 2023 earnings results today. Revenue of $7.7 billion was flat as reported and up 4.1% organically compared
Boston Scientific Corp (BSX) Q4 2022 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q4 2022 earnings call dated Feb. 01, 2023 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F. Mahoney -- Chairman
HUM Earnings: Highlights of Humana’s Q4 2022 financial results
Humana Inc. (NYSE: HUM) on Wednesday reported fourth-quarter 2022 results. Adjusted profit increased from last year, aided by a 7% growth in
BSX Infographic: Highlights of Boston Scientific’s Q4 2022 earnings report
Medical device maker Boston Scientific Corporation (NYSE: BSX) has announced financial results for the fourth quarter of 2022, reporting a decline in
Intuitive Surgical (ISRG) Earnings: 4Q22 Key Numbers
Intuitive Surgical, Inc. (NASDAQ: ISRG) reported revenue of $1.66 billion for the fourth quarter of 2022, which was up 7% year-over-year. GAAP
Johnson & Johnson (JNJ) Q4 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2022 earnings call dated Jan. 24, 2023 Corporate Participants: Jessica Moore -- Vice President of Investor Relations Joaquin
Boston Scientific Corp. (BSX) Q3 2022 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
Abbott (ABT) Q3 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q3 2022 earnings call dated Oct. 19, 2022 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing, and Acquisition
Infographic: Highlights of Intuitive Surgical’s Q3 2022 earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) said its third-quarter adjusted earnings remained unchanged year-over-year, while revenues increased in double digits.
Intuitive Surgical, Inc. (ISRG) Q3 2022 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ: ISRG) Q3 2022 earnings call dated Oct. 18, 2022 Corporate Participants: Brian King -- Treasurer and Head of Investor Relations
JNJ Earnings: Johnson & Johnson Q3 adj. profit drops despite higher sales
Johnson & Johnson (NYSE: JNJ) reported a decline in adjusted profit for the third quarter of 2022, despite a modest increase in net
ANGO Earnings: AngioDynamics Q1 loss widens. Revenue up 6%
AngioDynamics Inc. (NASDAQ: ANGO) on Friday reported a wider loss for the first quarter of 2023, despite a modest increase in revenues.
Medtronic PLC (MDT) Q1 2023 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q1 2023 earnings call dated Aug. 23, 2022 Corporate Participants: Ryan Weispfenning -- Vice President and Head of Investor Relations
ABIOMED, Inc. (ABMD) Q1 2023 Earnings Call Transcript
ABIOMED, Inc. (NASDAQ: ABMD) Q1 2023 earnings call dated Aug. 04, 2022 Corporate Participants: Nicole Nath -- Manager of Investor Relations Michael R. Minogue -- Chairman,
Boston Scientific Corp (BSX) Q2 2022 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q2 2022 earnings call dated Jul. 27, 2022 Corporate Participants: Lauren Tengler -- Director of Investor Relations Michael F.
Intuitive Surgical Inc. (ISRG) Earnings: 2Q22 Key Numbers
Intuitive Surgical Inc. (NASDAQ: ISRG) reported revenue of $1.52 billion for the second quarter of 2022, up 4% year-over-year. GAAP net income